| Literature DB >> 27822118 |
Nikolaj Eldrup1, Charlotte Cerqueira2, Louise de la Motte3, Lisbet Knudsen Rathenborg3, Allan K Hansen4.
Abstract
AIM: The Danish Vascular Registry (DVR), Karbase, is monitoring arterial and advanced vein interventions conducted at all vascular departments in Denmark. The main aim of the DVR is to improve the quality of treatment for patients undergoing vascular surgery in Denmark by using the registry for quality assessment and research. STUDY POPULATION: All patients undergoing vascular interventions (surgical and endovascular) at any vascular department in Denmark are registered in the DVR. The DVR was initiated in 1989, and each year, ∼9,000 procedures are added. By January 2016, >180,000 procedures have been recorded. Since 2001, data completeness has been >90% (compared to the Danish National Patient Register). MAIN VARIABLES: Variables include information on descriptive patient data (ie, age, sex, height, and weight) and comorbidity (ie, previous cardiovascular disease and diabetes). Process variable includes waiting time (time from event to medical contact and treatment) and the type of procedures conducted. Outcome variables for in-hospital complications (ie, wound complications, myocardial infarction, stroke, amputation, respiratory complications, and renal insufficiency) and 30-day patency are submitted. Variables for medical treatment (antithrombotic and statin treatment), amputation, and survival are extracted from nationwide, administrative registers.Entities:
Keywords: clinical registry; quality of care; vascular surgery
Year: 2016 PMID: 27822118 PMCID: PMC5094581 DOI: 10.2147/CLEP.S99506
Source DB: PubMed Journal: Clin Epidemiol ISSN: 1179-1349 Impact factor: 4.790
Indicators of Danish Vascular Registry from 2016–2017
| Procedure | Subgroup of procedure | 30-day mortality, myocaridal infarct, stroke, reintervention within 3 months, amputation 30 days, 3 months, and 12 months | Treatment duration (time from event, referral, examination, angiography, and treatment) | Wound infection and complications | Medical treatment with antithrombotic and statin at discharge, 3 months and 12 months | Access monitoring | Venous rethrombosis and pulmonary emboli after 3 months and 12 months | Length of stay |
|---|---|---|---|---|---|---|---|---|
| Carotid surgery | X | X | X | X | ||||
| Supraaortical reconstructions | X | X | ||||||
| Visceral reconstructions | ||||||||
| Renal artery | X | X | ||||||
| Mesenteric artery | X | X | ||||||
| Visceral arteries | X | X | ||||||
| Aorta/iliac–peripheral bypass | X | X | X | |||||
| Abdominal aortic aneurysm | ||||||||
| Open repair | ||||||||
| Rupture | X | X | X | |||||
| Acute | X | X | X | X | ||||
| Elective | X | X | X | X | ||||
| Others | X | X | ||||||
| Endovascular repair | ||||||||
| Acute and rupture | X | X | X | X | ||||
| Elective | X | X | X | X | ||||
| Others | X | X | ||||||
| Other aneurysms | X | X | ||||||
| Aorta–iliac TEA | X | X | X | |||||
| Other TEA | X | X | X | X | ||||
| Fem–fem crossover bypass | X | X | X | X | X | |||
| Infrainguinal bypass | ||||||||
| Femoral–popliteal bypass above knee | X | X | X | X | X | |||
| Prothesis | X | X | X | X | ||||
| In situ | X | X | X | X | ||||
| Others | X | X | X | |||||
| Femoral–popliteal bypass below knee | X | X | X | X | X | |||
| Prothesis | X | X | X | X | ||||
| In situ | X | X | X | X | ||||
| Others | X | X | X | |||||
| Femoral–crural bypass | ||||||||
| Prothesis | X | X | X | X | X | |||
| In situ | X | X | X | X | X | |||
| Others | X | X | X | |||||
| Other arterial bypasses 12 embolectomi/thrombectomi | X | X | X | |||||
| Graft | X | X | X | |||||
| Genuine vessel | X | X | X | |||||
| Arterial thrombolysis | X | X | X | X | ||||
| 14 endovascular | X | X | X | X | ||||
| Aortoiliac | X | X | X | |||||
| Femorocruralt | X | X | X | |||||
| Graft | X | X | X | |||||
| Others | X | |||||||
| Other arterial operations | X | X | ||||||
| Access surgery | X | |||||||
| Advanced venous surgery | X | |||||||
| Varicose veins | X | X | ||||||
| Thrombolysis/thrombectomi | X | X | ||||||
| Other venous surgeries | X | X | ||||||
| Reoperation | X | |||||||
| Other vascular operations | X | X |
Abbreviation: TEA, thromboendarterectomy.